Comparison sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism.
D000328:Adult; D001794:Blood Pressure; D001835:Body Weight; D005260:Female; D006111:Graves Disease / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007487:Ipodate / Q000627:therapeutic use*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D011441:Propylthiouracil / Q000627:therapeutic use*; D011674:Pulse; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood; D014285:Triiodothyronine, Reverse / Q000097:blood
D014284:Triiodothyronine; D014285:Triiodothyronine, Reverse; D011441:Propylthiouracil; D007487:Ipodate; D013974:Thyroxine